4

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: June 23, 2010
Period of Report: June 21, 2010
Accession Number: 0001209191-10-035483

View Document ↗ View on SEC.gov ↗